You are being silly. How soon people forget VRTX used to be in the same situation as VRUS is right now, stock would go up and down whenver key competitor MRK (used to be SGP) HCV drug data released. VRUS is going to follow the same path as VRTX did, no matter how good their drugs are, they are not immune from large swings.